| Product Code: ETC100283 | Publication Date: Jun 2021 | Updated Date: Nov 2025 | Product Type: Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 |
Colombia human insulin import market in 2024 continues to see significant shipments from top exporting countries such as South Korea, China, Germany, the United Kingdom, and the United States of America. The market concentration, as measured by the HHI, remained high in 2024, indicating a competitive landscape. However, the market experienced a decline in CAGR from 2020 to 2024 at -6.0%, with a notable decrease in growth rate from 2023 to 2024 at -48.46%. This data suggests a challenging environment for human insulin imports in Colombia, necessitating strategic adjustments for industry players.

Human insulin, used for diabetes management, holds a significant market share in Colombia pharmaceutical industry. The market is growing, driven by increasing prevalence of diabetes, aging population, and advancements in insulin delivery devices and formulations offering improved efficacy and patient convenience.
The Human Insulin Market in Colombia faces challenges such as affordability concerns and limited access to insulin therapy among diabetic patients. Additionally, the high cost of insulin medications and the lack of insurance coverage impact market accessibility. Moreover, competition from alternative diabetes treatments and the need for improved distribution channels pose challenges for market growth and patient care.
One of the significant challenges faced by the human insulin market in Colombia is the high cost associated with insulin therapy. Limited access to affordable healthcare and insulin products poses barriers to diabetes management, impacting market growth and patient outcomes.
The Colombia government has implemented policies to ensure access to human insulin for diabetes patients, including price controls, subsidies, and regulations to promote competition in the insulin market. Additionally, there are initiatives to raise public awareness about diabetes prevention and management, as well as to improve healthcare infrastructure for diabetes care.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Colombia Human Insulin Market Overview |
3.1 Colombia Country Macro Economic Indicators |
3.2 Colombia Human Insulin Market Revenues & Volume, 2021 & 2031F |
3.3 Colombia Human Insulin Market - Industry Life Cycle |
3.4 Colombia Human Insulin Market - Porter's Five Forces |
3.5 Colombia Human Insulin Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Colombia Human Insulin Market Revenues & Volume Share, By Diabetes Type, 2021 & 2031F |
3.7 Colombia Human Insulin Market Revenues & Volume Share, By Delivery Devices, 2021 & 2031F |
3.8 Colombia Human Insulin Market Revenues & Volume Share, By End-users, 2021 & 2031F |
4 Colombia Human Insulin Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Colombia Human Insulin Market Trends |
6 Colombia Human Insulin Market, By Types |
6.1 Colombia Human Insulin Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Colombia Human Insulin Market Revenues & Volume, By Type, 2021-2031F |
6.1.3 Colombia Human Insulin Market Revenues & Volume, By Analogue Insulin, 2021-2031F |
6.1.4 Colombia Human Insulin Market Revenues & Volume, By Traditional Human Insulin, 2021-2031F |
6.2 Colombia Human Insulin Market, By Diabetes Type |
6.2.1 Overview and Analysis |
6.2.2 Colombia Human Insulin Market Revenues & Volume, By Type 1 Diabetes, 2021-2031F |
6.2.3 Colombia Human Insulin Market Revenues & Volume, By Type 2 Diabetes, 2021-2031F |
6.2.4 Colombia Human Insulin Market Revenues & Volume, By Gestational Diabetes, 2021-2031F |
6.2.5 Colombia Human Insulin Market Revenues & Volume, By Prediabetes, 2021-2031F |
6.3 Colombia Human Insulin Market, By Delivery Devices |
6.3.1 Overview and Analysis |
6.3.2 Colombia Human Insulin Market Revenues & Volume, By Syringes, 2021-2031F |
6.3.3 Colombia Human Insulin Market Revenues & Volume, By Pens, 2021-2031F |
6.3.4 Colombia Human Insulin Market Revenues & Volume, By Pumps, 2021-2031F |
6.3.5 Colombia Human Insulin Market Revenues & Volume, By Others, 2021-2031F |
6.4 Colombia Human Insulin Market, By End-users |
6.4.1 Overview and Analysis |
6.4.2 Colombia Human Insulin Market Revenues & Volume, By Home Healthcare, 2021-2031F |
6.4.3 Colombia Human Insulin Market Revenues & Volume, By Hospitals, 2021-2031F |
6.4.4 Colombia Human Insulin Market Revenues & Volume, By Over The Counter (OTC), 2021-2031F |
6.4.5 Colombia Human Insulin Market Revenues & Volume, By Clinics, 2021-2031F |
6.4.6 Colombia Human Insulin Market Revenues & Volume, By Others, 2021-2031F |
7 Colombia Human Insulin Market Import-Export Trade Statistics |
7.1 Colombia Human Insulin Market Export to Major Countries |
7.2 Colombia Human Insulin Market Imports from Major Countries |
8 Colombia Human Insulin Market Key Performance Indicators |
9 Colombia Human Insulin Market - Opportunity Assessment |
9.1 Colombia Human Insulin Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Colombia Human Insulin Market Opportunity Assessment, By Diabetes Type, 2021 & 2031F |
9.3 Colombia Human Insulin Market Opportunity Assessment, By Delivery Devices, 2021 & 2031F |
9.4 Colombia Human Insulin Market Opportunity Assessment, By End-users, 2021 & 2031F |
10 Colombia Human Insulin Market - Competitive Landscape |
10.1 Colombia Human Insulin Market Revenue Share, By Companies, 2024 |
10.2 Colombia Human Insulin Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |